* Ask, Brief Advice, Smoking Cessation
“More smokers making more quit attempts more often” is the focus for the Ministry of Health’s Tobacco Control Plan.
Harbour Health has been rolling out the MoH’s ABC training designed to create an environment conducive to achieving this goal. However, we also understood that for general practice teams, the reality of incorporating this into your everyday consult was not easily realised.
The concept of the ATM (Ask, Triage, Manage) Tool is based on the paper based triage tool developed by Professor Paul McDonald and his team at Waterloo University, Canada.
Professor McDonald gave written permission for Harbour Health to transform and rebuild this paper based triage tool into a web based IT Support and Decision Tool which can be imbedded into the PMS Systems within Primary Care.
ATM introduces a method of triage which allows health professionals to provide a ‘custom fit’ service that appreciates how the level of support required for a successful quit attempt can range from self help through to intensive support.
ATM has been piloted and is now available to roll out to all Harbour Health affiliated general practices.
Click on the full evaluation to read more.
GASP Tool finalist in NZ Focus on Health Challenge
|
|
Harbour Health and CHS are really proud to announce that the GASP software tool (Giving Asthma Support to Patients) has been selected as a finalist in the annual New Zealand Focus on Health Challenge,
This annual business development challenge is to help fast track commercialisation of the New Zealand health market. It gives participants the chance to be connected to a network of influential health and business professionals in the United States and New Zealand, including investors, partners and buyers. The Challenge is designed to stimulate new product development, innovation, commercialisation and collaboration within New Zealand’s healthcare industry.
The GASP tool was selected as a finalist from an initial field of over 100 entries, which was narrowed down to the 10 finalists that represent world-leading health solutions which are capable of being marketed in the United States, the largest health market in the world. The judges commented that the calibre and innovation shown in the entries received has been staggering and they are examples of some of the world-leading health solutions being developed in this country.
Over the next six months the finalists will embark on an exhilarating journey. Their market readiness preparations include activities that will draw on the advice and expertise of the extensive Challenge Network and include one-on-one time with The Challenge's elite group of sponsors. With this invaluable assistance our finalists will be well prepared to tackle the world’s largest health market.
The web-based GASP tool is believed to be the first of its kind and was developed over a two year period by Harbour Health’s respiratory manager Wendy McNaughton and solution architect, Murray Speight from Comprehensive Health Services. The tool has been approved by Professor D. Robin Taylor and the Asthma and Respiratory Foundation.
Giving Asthma Support to Patients (GASP) is a web based, clinical assessment and decision support tool, for improved management of asthma. It also enables the differential diagnosis of asthma and Chronic Obstructive Pulmonary Disease (COPD) which is crucial for correct treatment of both conditions. Participants in the programme receive nurse consultations on dealing with asthma every few months. It produces a personalised individual take home document incorporating trigger advice, medication review and an action plan for both adults and children at the time of consultation. Research has shown that better assessment and long term management of asthma conditions will significantly improve health outcomes.
This is backed by measured outcomes from the use of GASP which includes a reduction in hospital admissions by 76 percent; a reduction in emergency visits by 58 percent, improved expiratory peak flow (56 percent) and a reduction in oral steroid usage (46 percent) in the GASP managed population.
GASP has been developed based on New Zealand, British and United States guidelines, and is designed for use by family physicians, respiratory nurses and trained respiratory therapists.
For further information pleaae contact: info@harbourhealth.org.nz
|
